• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致命性“薄型”恶性黑色素瘤。识别高危患者。

Lethal "thin" malignant melanoma. Identifying patients at risk.

作者信息

Slingluff C L, Vollmer R T, Reintgen D S, Seigler H F

机构信息

Duke University Medical Center, Durham, NC 27710.

出版信息

Ann Surg. 1988 Aug;208(2):150-61. doi: 10.1097/00000658-198808000-00004.

DOI:10.1097/00000658-198808000-00004
PMID:3401060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1493625/
Abstract

Thin melanomas can metastasize and be lethal. The purpose of this review was to identify negative risk factors in patients with melanomas less than 0.76 mm thick. Six hundred and eighty-one (681) such patients are reviewed in this study. Of those referred without metastatic disease (583 patients), metastases developed in 4.8% after a mean followup of 3.6 years. Of those referred with metastatic disease (98 patients), mortality was 35% after a mean followup of 5.9 years. Male patients (p less than 0.04) and patients with axial primaries (p less than 0.05) were at an increased risk of metastasis. Severe histologic regression was present in 40% of the primary lesions that metastasized and in only 17% of similar lesions that did not (p less than 0.001). Increased age was associated with increased local skin metastases, but not with increased nodal or distant metastases. A prognostic model was designed, using two clinical risk factors (axial primary site and male sex) and two histologic risk factors (Clark's Level IV and severe histologic regression). The prognostic model identified a low-risk population--women with extremity primaries--with an actuarial risk of metastasis at 10 years that was less than 3%. Patients with either (1) both clinical risk factors or (2) one clinical risk factor and one histologic risk factor were identified as high-risk patients. Their actuarial risk of metastasis was 11% at 5 years and 22% at 10 years (p = 0.0084). Identifying high-risk and low-risk patients with thin melanomas may improve guidelines for the application of adjuvant therapies to this population.

摘要

薄型黑色素瘤可发生转移并具有致死性。本综述的目的是确定厚度小于0.76 mm的黑色素瘤患者的负性危险因素。本研究对681例此类患者进行了回顾。在那些初诊时无转移疾病的患者(583例)中,平均随访3.6年后,4.8%发生了转移。在那些初诊时已有转移疾病的患者(98例)中,平均随访5.9年后,死亡率为35%。男性患者(p<0.04)和原发灶位于躯干部位的患者(p<0.05)发生转移的风险增加。40%发生转移的原发灶存在严重组织学消退,而未发生转移的相似病灶中仅有17%存在严重组织学消退(p<0.001)。年龄增加与局部皮肤转移增加相关,但与淋巴结或远处转移增加无关。利用两个临床危险因素(躯干部位原发和男性)和两个组织学危险因素(克拉克分级IV级和严重组织学消退)设计了一个预后模型。该预后模型确定了一个低风险人群——四肢原发灶的女性——其10年转移的精算风险小于3%。具有以下情况之一的患者被确定为高风险患者:(1)两个临床危险因素均存在;或(2)一个临床危险因素和一个组织学危险因素。他们5年转移的精算风险为11%,10年为22%(p=0.0084)。识别薄型黑色素瘤的高风险和低风险患者可能会改善针对该人群辅助治疗应用的指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/1493625/1c863fd1bb2e/annsurg00186-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/1493625/084d17fc95c0/annsurg00186-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/1493625/1c863fd1bb2e/annsurg00186-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/1493625/084d17fc95c0/annsurg00186-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/1493625/1c863fd1bb2e/annsurg00186-0046-b.jpg

相似文献

1
Lethal "thin" malignant melanoma. Identifying patients at risk.致命性“薄型”恶性黑色素瘤。识别高危患者。
Ann Surg. 1988 Aug;208(2):150-61. doi: 10.1097/00000658-198808000-00004.
2
"Thin" malignant melanoma: risk factors and clinical management.
Ann Plast Surg. 1992 Jan;28(1):89-94. doi: 10.1097/00000637-199201000-00023.
3
Prognostic factors for survival in malignant melanoma of the eyelid skin.眼睑皮肤恶性黑色素瘤生存的预后因素。
Ophthalmic Plast Reconstr Surg. 2000 Jul;16(4):250-7. doi: 10.1097/00002341-200007000-00002.
4
Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.薄型黑色素瘤:基于30年临床经验的预测性致死特征
Ann Surg. 2003 Oct;238(4):528-35; discussion 535-7. doi: 10.1097/01.sla.0000090446.63327.40.
5
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.黑色素瘤的多因素分析:比较克拉克(Clark)和布雷斯洛(Breslow)分期方法的预后组织病理学特征
Ann Surg. 1978 Dec;188(6):732-42. doi: 10.1097/00000658-197812000-00004.
6
Malignant melanoma in the elderly.老年人恶性黑色素瘤。
J Clin Oncol. 1987 Jan;5(1):100-6. doi: 10.1200/JCO.1987.5.1.100.
7
Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma.立体学评估体积加权平均核体积作为“薄型”恶性黑色素瘤预后的预测指标
J Invest Dermatol. 1992 Aug;99(2):180-3. doi: 10.1111/1523-1747.ep12616803.
8
Survival with regional and distant metastases from cutaneous malignant melanoma.皮肤恶性黑色素瘤伴区域和远处转移的生存情况。
Surg Gynecol Obstet. 1991 Apr;172(4):262-8.
9
The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.消退性薄恶性黑色素瘤:一种具有转移潜能的独特病变。
Cancer. 1978 Nov;42(5):2282-92. doi: 10.1002/1097-0142(197811)42:5<2282::aid-cncr2820420528>3.0.co;2-v.
10
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).黑色素瘤的多因素分析。IV. 200例有远处转移(III期)黑色素瘤患者的预后因素
J Clin Oncol. 1983 Feb;1(2):126-34. doi: 10.1200/JCO.1983.1.2.126.

引用本文的文献

1
Tumoral inflammatory infiltrate does not predict metastases in thin primary cutaneous melanomas.肿瘤性炎症浸润并不能预测薄型原发性皮肤黑色素瘤的转移。
An Bras Dermatol. 2023 Nov-Dec;98(6):793-798. doi: 10.1016/j.abd.2022.09.011. Epub 2023 Jun 22.
2
Is It Time to Supersede the Diagnostic Term "Melanoma In Situ with Regression?" A Narrative Review.是时候取代“伴有消退的原位黑色素瘤”这一诊断术语了吗?一篇叙述性综述。
Dermatopathology (Basel). 2023 Mar 22;10(1):120-127. doi: 10.3390/dermatopathology10010018.
3
Is There a Relationship Between TILs and Regression in Melanoma?

本文引用的文献

1
Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis.恶性黑色素瘤;诊断及预后标准的临床病理分析
Cancer. 1953 Jan;6(1):1-45. doi: 10.1002/1097-0142(195301)6:1<1::aid-cncr2820060102>3.0.co;2-c.
2
The intra-lesional variation of type, level of invasion, and tumour thickness of primary cutaneous malignant melanoma.原发性皮肤恶性黑色素瘤的类型、浸润深度和肿瘤厚度的瘤内变化。
Acta Pathol Microbiol Scand A. 1980 Sep;88(5):269-74. doi: 10.1111/j.1699-0463.1980.tb02496.x.
3
Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).
肿瘤浸润淋巴细胞与黑色素瘤消退之间存在关系吗?
Ann Surg Oncol. 2022 May;29(5):2854-2866. doi: 10.1245/s10434-021-11251-z. Epub 2022 Jan 21.
4
Microvessel Density in Patients with Cutaneous Melanoma: An Up-to-Date Systematic Review and Meta-Analysis.皮肤黑色素瘤患者的微血管密度:最新系统评价与荟萃分析
J Skin Cancer. 2017;2017:2049140. doi: 10.1155/2017/2049140. Epub 2017 Dec 26.
5
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.原发性皮肤黑色素瘤的消退:病因发病机制及临床意义。
Lab Invest. 2017 Jun;97(6):657-668. doi: 10.1038/labinvest.2017.8. Epub 2017 Feb 27.
6
Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.薄型黑色素瘤的消退与前哨淋巴结活检阴性后的淋巴结复发相关。
Cancer Med. 2016 Oct;5(10):2832-2840. doi: 10.1002/cam4.922. Epub 2016 Sep 27.
7
Breslow density is a novel prognostic feature in cutaneous malignant melanoma.布雷斯洛厚度是皮肤恶性黑色素瘤的一种新的预后特征。
Histopathology. 2017 Jan;70(2):264-272. doi: 10.1111/his.13060. Epub 2016 Oct 10.
8
Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.伴有脑转移的皮肤黑色素瘤:193例患者的报告及新观察结果
PLoS One. 2016 May 23;11(5):e0156115. doi: 10.1371/journal.pone.0156115. eCollection 2016.
9
Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-(99m)Tc-nanocolloid hybrid tracer versus (99m)Tc-nanocolloid.用于头颈部恶性肿瘤前哨淋巴结活检的放射性与荧光混合示踪剂的评估:比较吲哚菁绿-(99m)锝纳米胶体混合示踪剂与(99m)锝纳米胶体的前瞻性随机临床试验
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1631-1638. doi: 10.1007/s00259-015-3093-7. Epub 2015 May 31.
10
Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain.使用苏木精和伊红染色以及抗磷酸化组蛋白3免疫组化染色,对薄转移性黑色素瘤与无转移的薄黑色素瘤的肿瘤有丝分裂率进行分析。
Am J Dermatopathol. 2014 Jan;36(1):64-7. doi: 10.1097/DAD.0b013e31829433b6.
皮肤恶性黑色素瘤(I期)的肿瘤厚度及首次复发部位和时间
Br J Surg. 1980 Aug;67(8):543-6. doi: 10.1002/bjs.1800670804.
4
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions.厚度为0.76 - 1.69毫米的黑色素瘤患者的预后因素。对“薄”IV级病变的评估。
Ann Surg. 1982 Jan;195(1):30-4. doi: 10.1097/00000658-198201001-00005.
5
Metastasis and death in patients with thin melanomas (less than 0.76 mm).薄黑色素瘤(厚度小于0.76毫米)患者的转移与死亡情况
Ann Surg. 1983 Jul;198(1):63-4. doi: 10.1097/00000658-198307000-00012.
6
Biologic behavior of thin malignant melanomas with regressive changes.
Arch Surg. 1983 Jan;118(1):41-4. doi: 10.1001/archsurg.1983.01390010031008.
7
Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.患者性别、肿瘤部位及有丝分裂率在薄型(小于或等于1.5毫米)黑色素瘤中的预后意义。
Arch Dermatol Res. 1984;276(3):151-5. doi: 10.1007/BF00414011.
8
The histogenesis and biologic behavior of primary human malignant melanomas of the skin.原发性人类皮肤恶性黑色素瘤的组织发生及生物学行为
Cancer Res. 1969 Mar;29(3):705-27.
9
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.厚度、横截面积及浸润深度在皮肤黑色素瘤预后中的作用
Ann Surg. 1970 Nov;172(5):902-8. doi: 10.1097/00000658-197011000-00017.
10
Regression in malignant melanoma. A histologic feature without independent prognostic significance.恶性黑色素瘤中的消退。一种无独立预后意义的组织学特征。
Cancer. 1985 Nov 1;56(9):2287-91. doi: 10.1002/1097-0142(19851101)56:9<2287::aid-cncr2820560924>3.0.co;2-y.